down arrow

Nakanishi, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3642500007
  • TKS: 7716
JPY
3,015.00
-60 (-1.95%)

Sep 18

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Nakanishi, Inc. stock-summary
stock-summary
Nakanishi, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.04%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
24,746 Million
(Quarterly Results - Jun 2026)
Net Profit:
4,164 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 280,343 Million (Mid Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.24

stock-summary
Return on Equity

12.82%

stock-summary
Price to Book

2.41

Footer loading